POLARIS INSIGHTS

Tarsus Pharmaceuticals, Inc. GAAP EPS of -$14. 40 misses by $10. 38, revenue of $194. 5M beats by $3. 72M

This story focuses on Tarsus Pharmaceuticals, Inc. GAAP EPS of -$14. 40 misses by $10. 38, revenue of $194. 5M….

More from the Markets desk